Inventor · disambiguated record
Mario Cardozo
Also filed as: CARDOZO MARIO · CARDOZO MARIO G
23 granted patents·13 pending applications·665 citations·filing 1995–2024
96Inventor score
Files withBOEHRINGER INGELHEIM PHARMA11NURIX THERAPEUTICS INC11AMGEN INC6INTERLINE THERAPEUTICS INC3BEKKALI YOUNES1
Top patents by PatentIndex Score
36 records- 0198US6770639B2Heterocyclic compounds useful as inhibitors of tyrosine kinasesBOEHRINGER INGELHEIM PHARMA·Filed 2002·Granted Aug 3, 2004·205 cites·5 claims
- 0298US6506769B2Heterocyclic compounds useful as inhibitors of tyrosine kinasesBOEHRINGER INGELHEIM PHARMA·Filed 2001·Granted Jan 14, 2003·240 cites·32 claims
- 0397US11530229B2Cyano cyclobutyl compounds for CBL-B inhibition and uses thereofNURIX THERAPEUTICS INC·Filed 2020·Granted Dec 20, 2022·12 cites·71 claims
- 0497US11464802B23-substituted piperidine compounds for Cbl-b inhibition, and use thereofNURIX THERAPEUTICS INC·Filed 2020·Granted Oct 11, 2022·14 cites·53 claims
- 0597US11401267B2Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereofNURIX THERAPEUTICS INC·Filed 2020·Granted Aug 2, 2022·11 cites·32 claims
- 0694US11951133B23-substituted piperidine compounds for Cbl-b inhibition, and use thereofNURIX THERAPEUTICS INC·Filed 2022·Granted Apr 9, 2024·2 cites·36 claims
- 0793US7199119B2Antiinflammation agentsAMGEN INC·Filed 2003·Granted Apr 3, 2007·75 cites·11 claims
- 0892US12485144B23-substituted piperidine compounds for Cbl-b inhibition, and use thereofNURIX THERAPEUTICS INC·Filed 2024·Granted Dec 2, 2025·1 cites·40 claims
- 0992US12049471B2Cyano cyclobutyl compounds for Cbl-b inhibition and uses thereofNURIX THERAPEUTICS INC·Filed 2022·Granted Jul 30, 2024·1 cites·16 claims
- 1090US12234230B2Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereofNURIX THERAPEUTICS INC·Filed 2022·Granted Feb 25, 2025·1 cites·5 claims
- 1186US7635695B2Antiinflammation agentsAMGEN INC·Filed 2007·Granted Dec 22, 2009·10 cites·20 claims
- 1284US7268152B2Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereofBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Sep 11, 2007·24 cites·11 claims
- 1381US11306107B2Compounds that inhibit MCL-1 proteinAMGEN INC·Filed 2017·Granted Apr 19, 2022·2 cites·11 claims
- 1481US2025136590A1Substituted benzyl-triazole compounds for cbl-b inhibition, and further uses thereofNURIX THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1580US8153631B2Triazole compounds and uses related theretoPOWERS JAY P·Filed 2009·Granted Apr 10, 2012·7 cites·6 claims
- 1680US2024409555A1Cyano cyclobutyl compounds for cbl-b inhibition and uses thereofNURIX THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1777US6268365B1Src family SH2 domain inhibitorsBOEHRINGER INGELHEIM PHARMA·Filed 1999·Granted Jul 31, 2001·31 cites·5 claims
- 1872US7550473B2Pyrimidine derivatives useful as inhibitors of PKC-thetaBOEHRINGER INGELHEIM PHARMA·Filed 2004·Granted Jun 23, 2009·6 cites·13 claims
- 1967US2025066356A1Lrrk2 inhibitorsINTERLINE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2063US6794158B2Fluorescence polarization assayBOEHRINGER INGELHEIM PHARMA·Filed 2002·Granted Sep 21, 2004·7 cites·31 claims
- 2163US2025270209A1Lrrk2 inhibitorsINTERLINE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2262US7683059B2Triazole compounds and uses related theretoAMGEN INC·Filed 2004·Granted Mar 23, 2010·2 cites·18 claims
- 2361US2025346593A1Imidazo(1,2-1)pyridine derivatives as ripk2 inhibitorsINTERLINE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2455US8212040B2Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereofBEKKALI YOUNES·Filed 2006·Granted Jul 3, 2012·0 cites·11 claims
- 2552US6054470ASrc family SH2 domain inhibitorsBOEHRINGER INGELHEIM PHARMA·Filed 1998·Granted Apr 25, 2000·7 cites·12 claims
- 2652US2004242613A1Pyrimidine derivatives useful as inhibitors of PKC-thetaBOEHRINGER INGELHEIM PHARMA·Filed 2004·Application pending·0 cites
- 2751US2022387395A1Urea, amide, and substituted heteroaryl compounds for cbl-b inhibitionNURIX THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2850US2022324835A1Inhibitors of cbl-b and methods of use thereofNURIX THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2946US2007244155A1Bicyclic carboxylic acid derivatives useful for treating metabolic disordersAMGEN INC·Filed 2007·Application pending·0 cites
- 3045US6284768B1Src family SH2 domain inhibitorsBOEHRINGER INGELHEIM PHARMA·Filed 1999·Granted Sep 4, 2001·4 cites·10 claims
- 3144US5837704A2-heteroaryl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-E! 1,4!diazepines and their use in the prevention or treatment of HIV infectionBOEHRINGER INGELHEIM PHARMA·Filed 1995·Granted Nov 17, 1998·3 cites·7 claims
- 3243US7763624B2Substituted pyrazolo[3,4-d]pyrimidines as ACK-1 and LCK inhibitorsAMGEN INC·Filed 2006·Granted Jul 27, 2010·0 cites·34 claims
- 3343US2006276515A1Soluble Epoxide Hydrolase Inhibitors and Methods of Using SameCYWIN CHARLES L·Filed 2006·Application pending·0 cites
- 3442US2005124002A1Method for selecting compounds from a combinatorial or other chemistry library for efficient synthesisBOEHRINGER INGELHEIM PHARMA·Filed 2005·Application pending·0 cites
- 3542US2006293292A1METHODS OF USING ACYL HYDRAZONES AS sEH INHIBITORSBOEHRINGER INGELHEIM INT·Filed 2006·Application pending·0 cites
- 3636US2002127608A1Method for selecting compounds from a combinatorial or other chemistry library for efficient synthesisFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mario Cardozo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →